SERA
SERA
NASDAQ · Biotechnology

Sera Prognostics Inc-A

$2.52
+0.20 (+8.62%)
As of Feb 8, 2:12 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 14.50M 14.53M 15.74M
Net Income -1,413,235 -1,603,701 -1,555,725
EPS
Profit Margin -9.8% -11.0% -9.9%
Rev Growth -0.7% +22.5% +19.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 28.47M 26.23M 27.41M
Total Equity 39.73M 39.07M 37.99M
D/E Ratio 0.72 0.67 0.72
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,727,030 -1,702,906 -1,797,734
Free Cash Flow -928,870 -884,905 -1,153,129